Global Human Cytomegalovirus Envelope Glycoprotein B Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Human Cytomegalovirus Envelope Glycoprotein B

• 1.1 Definition of Human Cytomegalovirus Envelope Glycoprotein B
• 1.2 Human Cytomegalovirus Envelope Glycoprotein B Segment by Type
  • 1.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 CSJ-148
  • 1.2.3 CyMVectin
  • 1.2.4 TRL-345
  • 1.2.5 PPCM
  • 1.2.6 Cytomegalovirus Vaccine
  • 1.2.7 Others
• 1.3 Human Cytomegalovirus Envelope Glycoprotein B Segment by Applications
  • 1.3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Infectious Disease
  • 1.3.3 Oncology
  • 1.3.4 Women's Health
  • 1.3.5 Others
• 1.4 Global Human Cytomegalovirus Envelope Glycoprotein B Overall Market
  • 1.4.1 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (2014-2025)
  • 1.4.2 Global Human Cytomegalovirus Envelope Glycoprotein B Production (2014-2025)
  • 1.4.3 North America Human Cytomegalovirus Envelope Glycoprotein B Status and Prospect (2014-2025)
  • 1.4.4 Europe Human Cytomegalovirus Envelope Glycoprotein B Status and Prospect (2014-2025)
  • 1.4.5 China Human Cytomegalovirus Envelope Glycoprotein B Status and Prospect (2014-2025)
  • 1.4.6 Japan Human Cytomegalovirus Envelope Glycoprotein B Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Status and Prospect (2014-2025)
  • 1.4.8 India Human Cytomegalovirus Envelope Glycoprotein B Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Human Cytomegalovirus Envelope Glycoprotein B
• 2.3 Manufacturing Process Analysis of Human Cytomegalovirus Envelope Glycoprotein B
• 2.4 Industry Chain Structure of Human Cytomegalovirus Envelope Glycoprotein B

3 Development and Manufacturing Plants Analysis of Human Cytomegalovirus Envelope Glycoprotein B

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Human Cytomegalovirus Envelope Glycoprotein B
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Human Cytomegalovirus Envelope Glycoprotein B Production and Capacity Analysis
• 4.2 Human Cytomegalovirus Envelope Glycoprotein B Revenue Analysis
• 4.3 Human Cytomegalovirus Envelope Glycoprotein B Price Analysis
• 4.4 Market Concentration Degree

5 Human Cytomegalovirus Envelope Glycoprotein B Regional Market Analysis

• 5.1 Human Cytomegalovirus Envelope Glycoprotein B Production by Regions
  • 5.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Production by Regions
  • 5.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Regions
• 5.2 Human Cytomegalovirus Envelope Glycoprotein B Consumption by Regions
• 5.3 North America Human Cytomegalovirus Envelope Glycoprotein B Market Analysis
  • 5.3.1 North America Human Cytomegalovirus Envelope Glycoprotein B Production
  • 5.3.2 North America Human Cytomegalovirus Envelope Glycoprotein B Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Human Cytomegalovirus Envelope Glycoprotein B Import and Export
• 5.4 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Analysis
  • 5.4.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Production
  • 5.4.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Human Cytomegalovirus Envelope Glycoprotein B Import and Export
• 5.5 China Human Cytomegalovirus Envelope Glycoprotein B Market Analysis
  • 5.5.1 China Human Cytomegalovirus Envelope Glycoprotein B Production
  • 5.5.2 China Human Cytomegalovirus Envelope Glycoprotein B Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Human Cytomegalovirus Envelope Glycoprotein B Import and Export
• 5.6 Japan Human Cytomegalovirus Envelope Glycoprotein B Market Analysis
  • 5.6.1 Japan Human Cytomegalovirus Envelope Glycoprotein B Production
  • 5.6.2 Japan Human Cytomegalovirus Envelope Glycoprotein B Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Human Cytomegalovirus Envelope Glycoprotein B Import and Export
• 5.7 Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Market Analysis
  • 5.7.1 Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Production
  • 5.7.2 Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Import and Export
• 5.8 India Human Cytomegalovirus Envelope Glycoprotein B Market Analysis
  • 5.8.1 India Human Cytomegalovirus Envelope Glycoprotein B Production
  • 5.8.2 India Human Cytomegalovirus Envelope Glycoprotein B Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Human Cytomegalovirus Envelope Glycoprotein B Import and Export

6 Human Cytomegalovirus Envelope Glycoprotein B Segment Market Analysis (by Type)

• 6.1 Global Human Cytomegalovirus Envelope Glycoprotein B Production by Type
• 6.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type
• 6.3 Human Cytomegalovirus Envelope Glycoprotein B Price by Type

7 Human Cytomegalovirus Envelope Glycoprotein B Segment Market Analysis (by Application)

• 7.1 Global Human Cytomegalovirus Envelope Glycoprotein B Consumption by Application
• 7.2 Global Human Cytomegalovirus Envelope Glycoprotein B Consumption Market Share by Application (2014-2019)

8 Human Cytomegalovirus Envelope Glycoprotein B Major Manufacturers Analysis

• 8.1 Astellas Pharma Inc.
  • 8.1.1 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Production Sites and Area Served
  • 8.1.2 Astellas Pharma Inc. Product Introduction, Application and Specification
  • 8.1.3 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Trellis Bioscience, Inc.
  • 8.2.1 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Production Sites and Area Served
  • 8.2.2 Trellis Bioscience, Inc. Product Introduction, Application and Specification
  • 8.2.3 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Vakzine Projekt Management GmbH
  • 8.3.1 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Production Sites and Area Served
  • 8.3.2 Vakzine Projekt Management GmbH Product Introduction, Application and Specification
  • 8.3.3 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 VBI Vaccine Inc
  • 8.4.1 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Production Sites and Area Served
  • 8.4.2 VBI Vaccine Inc Product Introduction, Application and Specification
  • 8.4.3 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Vical Incorporated
  • 8.5.1 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Production Sites and Area Served
  • 8.5.2 Vical Incorporated Product Introduction, Application and Specification
  • 8.5.3 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served

9 Development Trend of Analysis of Human Cytomegalovirus Envelope Glycoprotein B Market

• 9.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Trend Analysis
  • 9.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Human Cytomegalovirus Envelope Glycoprotein B Regional Market Trend
  • 9.2.1 North America Human Cytomegalovirus Envelope Glycoprotein B Forecast 2019-2025
  • 9.2.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Forecast 2019-2025
  • 9.2.3 China Human Cytomegalovirus Envelope Glycoprotein B Forecast 2019-2025
  • 9.2.4 Japan Human Cytomegalovirus Envelope Glycoprotein B Forecast 2019-2025
  • 9.2.5 Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Forecast 2019-2025
  • 9.2.6 India Human Cytomegalovirus Envelope Glycoprotein B Forecast 2019-2025
• 9.3 Human Cytomegalovirus Envelope Glycoprotein B Market Trend (Product Type)
• 9.4 Human Cytomegalovirus Envelope Glycoprotein B Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Human Cytomegalovirus Envelope Glycoprotein B Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List